GX1
GENXONE NEWCONNECT LISTED

Shareholders

as of August 12, 2026 · source: notifications under Art. 69 of the Offering Act · 4 entities above 5% of votes

FREE FLOAT
33.39%
1,103,602 shares
LARGEST STAKE
40.31%
Diagnostyka S.A.
TOP 3 CONCENTRATION
60.94%
3 entities above 5% of votes
LATEST CHANGE
June 23, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 3,304,820 (report, Aug 12, 2026)
SHAREHOLDERS ≥5% OF VOTES 66.61% FREE FLOAT 33.39%
Diagnostyka S.A. 40.31%
1,332,138 shares NOTIFICATION: Aug 12, 2026
Michał Kaszuba 12.97%
428,470 shares NOTIFICATION: Aug 12, 2026
Carpathia Capital Alternatywna Spółka Inwestycyjna Spółka Akcyjna 7.66%
253,069 shares NOTIFICATION: Aug 12, 2026
Porozumienie obejmujące Joannę Anioł-Adamczyk oraz Marcina Adamczyka 5.67%
187,541 shares NOTIFICATION: Aug 12, 2026
Other 33.39%
1,103,602 shares composition undisclosed

Announcement history

crossings above/below the 5% / 10% / 20% thresholds
Jun 23, 2026
ESPI (wykaz z WZ) — baseline reading
Diagnostyka S.A.: new in the registry, 40.31%
→

Capital and votes

Number of shares
3,304,820
ISIN
PLGENXN00013
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.